NOMAD Power Solutions, Inc.
NMADHealthcare|Biotechnology|US
$3.60
+0.11 (+3.15%)
DCF Value
$0.08
Tangible Book / Share
$1.85
Cash / Share
$0.94
Financials
Financial Snapshot
Market Cap
$44.5M
Enterprise Value
$32.9M
Revenue (TTM)
$0.00
Net Income (TTM)
-$8.7M
Cash & Investments
$12.7M
Net Cash
$11.6M
Free Cash Flow (TTM)
-$5.5M
Operating CF (TTM)
-$5.5M
Debt/Equity
0.05
Cash Runway & Burn Rate
Cash on Hand
$12.7M
Quarterly Burn
$1.4M
Monthly Burn
$454.8K
Est. Runway
~9.3 quarters
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $199.9K | $1.3M | $4.3M | $2.6M | $5.1M | $4.8M | $5.4M | $4.2M | $1.0M | $5.1M | $12.7M | |
| Operating Cash Flow | -$1.7M | -$1.4M | -$1.5M | -$1.7M | -$2.1M | -$4.1M | -$4.6M | -$4.3M | -$3.2M | -$3.1M | -$5.5M | |
| Free Cash Flow | -$1.7M | -$1.4M | -$1.5M | -$1.7M | -$2.1M | -$4.1M | -$4.6M | -$4.3M | -$3.2M | -$3.1M | -$5.5M | |
| Capital Expenditure | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$3.00 | $0.00 | -$4.00 | $0.00 | $0.00 | |
| Financing Cash Flow | $1.7M | $2.5M | $4.5M | $0.00 | $4.6M | $3.9M | $5.1M | $3.1M | $0.00 | $10.3M | $26.9M |
R&D Spending
R&D (TTM)
$498.4K
R&D Intensity
—
R&D Growth vs Prior
+95.5%
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| R&D Expense | $1.3M | $467.3K | $40.7K | $820.9K | $1.2M | $1.7M | $1.3M | $898.1K | $726.2K | $254.9K | $498.4K | |
| SG&A | $833.8K | $1.3M | $2.1M | $1.7M | $2.0M | $5.0M | $5.0M | $4.2M | $2.8M | $4.9M | $7.5M |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $230.3K | |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$230.3K | |
| R&D | $1.3M | $467.3K | $40.7K | $820.9K | $1.2M | $1.7M | $1.3M | $898.1K | $726.2K | $254.9K | $498.4K | |
| SG&A | $833.8K | $1.3M | $2.1M | $1.7M | $2.0M | $5.0M | $5.0M | $4.2M | $2.8M | $4.9M | $7.5M | |
| Operating Income | -$2.1M | -$1.8M | -$2.1M | -$2.5M | -$3.3M | -$6.7M | -$6.3M | -$5.1M | -$3.6M | -$5.1M | -$8.0M | |
| Interest Expense | $183.00 | $1.4K | $4.9K | $0.00 | $3.7K | $7.4K | $8.9K | $16.2K | $16.8K | $9.2K | $6.5K | |
| Pretax Income | -$2.1M | -$1.8M | -$2.1M | -$2.4M | -$3.3M | -$6.7M | -$6.3M | -$5.1M | -$3.6M | -$6.0M | -$8.9M | |
| Net Income | -$2.1M | -$1.8M | -$2.1M | -$2.4M | -$3.3M | -$6.7M | -$6.3M | -$5.1M | -$3.6M | -$6.0M | -$8.7M | |
| EPS (Diluted) | -2.68 | -1.94 | -2.18 | -2.20 | -2.89 | -5.00 | -4.00 | -2.66 | -1.59 | -1.26 | -1.00 | |
| EBITDA | $183.00 | $1.4K | $4.9K | -$2.4M | $0.00 | -$6.7M | -$6.3M | -$5.1M | -$3.6M | -$6.0M | -$8.9M | |
| Shares Out. (M) | 0.80 | 0.93 | 0.98 | 1.12 | 1.13 | 1.35 | 1.58 | 1.92 | 2.25 | 48.41 | 13.48 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $199.9K | $1.3M | $4.3M | $2.6M | $5.1M | $4.8M | $5.4M | $4.2M | $1.0M | $5.1M | $12.7M | |
| Short-Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Current Assets | $433.4K | $1.4M | $4.3M | $2.7M | $5.2M | $5.1M | $5.6M | $4.3M | $1.0M | $5.2M | $19.3M | |
| Total Assets | $433.4K | $1.4M | $4.3M | $2.7M | $5.2M | $5.1M | $5.6M | $4.3M | $1.1M | $12.7M | $26.6M | |
| Total Current Liabilities | $218.7K | $373.0K | $210.9K | $237.9K | $216.5K | $302.9K | $395.8K | $313.9K | $318.3K | $1.3M | $1.5M | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $161.0K | |
| Total Liabilities | $218.7K | $373.0K | $210.9K | $237.9K | $216.5K | $302.9K | $395.8K | $313.9K | $318.3K | $1.8M | $1.7M | |
| Stockholders' Equity | $214.8K | $995.0K | $4.1M | $2.4M | $5.0M | $4.8M | $5.2M | $4.0M | $827.2K | $9.7M | $23.9M | |
| Retained Earnings | -$20.7M | -$22.5M | -$24.6M | -$27.1M | -$30.4M | -$37.1M | -$43.4M | -$48.5M | -$52.1M | -$58.1M | -$62.2M |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.7M | -$1.4M | -$1.5M | -$1.7M | -$2.1M | -$4.1M | -$4.6M | -$4.3M | -$3.2M | -$3.1M | -$5.5M | |
| Capital Expenditure | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$3.00 | $0.00 | -$4.00 | $0.00 | $0.00 | |
| Free Cash Flow | -$1.7M | -$1.4M | -$1.5M | -$1.7M | -$2.1M | -$4.1M | -$4.6M | -$4.3M | -$3.2M | -$3.1M | -$5.5M | |
| Investing Cash Flow | $104.1K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$3.2M | -$9.7M | |
| Financing Cash Flow | $1.7M | $2.5M | $4.5M | $0.00 | $4.6M | $3.9M | $5.1M | $3.1M | $0.00 | $10.3M | $26.9M | |
| Issuance of Stock | $1.8M | $2.5M | $4.5M | $0.00 | $4.6M | $3.7M | $5.1M | $3.1M | $0.00 | $10.3M | $26.9M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $287.2K | $70.7K | $785.6K | $748.7K | $1.3M | $2.6M | $1.5M | $0.00 | $418.4K | $1.6M | $1.9M | |
| Net Change in Cash | $174.6K | $1.1M | $3.0M | -$1.7M | $2.5M | -$245.5K | $529.6K | -$1.1M | -$3.2M | $4.1M | $11.8M |
Dilution Tracker
Shares outstanding grew 4192.5% over 5 years — significant dilution
Shares Outstanding
12M
5-Year Share Growth
+4192.5%
Stock Issuance (TTM)
$26.9M
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 0.80 | 0.93 | 0.98 | 1.12 | 1.13 | 1.35 | 1.58 | 1.92 | 2.25 | 48.41 | 13.48 | |
| Change vs Prior % | — | 16.6% | 5.3% | 14.0% | 1.0% | 19.5% | 17.4% | 21.1% | 17.4% | 2052.4% | -72.2% | |
| Stock Issuance | $1.8M | $2.5M | $4.5M | $0.00 | $4.6M | $3.7M | $5.1M | $3.1M | $0.00 | $10.3M | $26.9M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $287.2K | $70.7K | $785.6K | $748.7K | $1.3M | $2.6M | $1.5M | $0.00 | $418.4K | $1.6M | $1.9M |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | -994.0% | -181.7% | -51.7% | -100.3% | -65.1% | -140.5% | -122.2% | -127.3% | -433.5% | -62.2% | -74.8% | |
| ROA % | -492.5% | -132.2% | -49.2% | -91.3% | -62.4% | -132.1% | -113.5% | -118.1% | -313.0% | -47.2% | -32.6% | |
| ROIC % | -993.1% | -181.7% | -51.6% | -102.3% | -64.2% | -140.3% | -122.2% | -127.4% | -431.9% | -42.3% | -30.5% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Gross Profit | -100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Operating Income | 19.3% | 15.2% | -18.1% | -16.5% | -31.2% | -105.7% | 6.1% | 19.3% | 29.8% | -43.0% | |
| Net Income | 25.1% | 15.3% | -18.0% | -14.4% | -33.8% | -106.1% | 6.2% | 19.4% | 29.5% | -67.6% | |
| EPS (Diluted) | 26.8% | 27.6% | -12.4% | -0.9% | -31.4% | -73.0% | 20.0% | 33.5% | 40.2% | 20.8% | |
| Operating Cash Flow | 23.1% | 15.8% | -7.0% | -10.8% | -27.3% | -94.4% | -11.3% | 6.9% | 26.3% | 3.0% | |
| Free Cash Flow | 23.1% | 15.8% | -7.0% | -10.8% | -27.3% | -94.4% | -11.3% | 6.9% | 26.3% | 3.0% | |
| R&D Expense | -37.8% | -64.1% | -91.3% | 1916.8% | 49.1% | 41.9% | -22.3% | -33.4% | -19.1% | -64.9% | |
| SG&A Expense | 10.5% | 61.0% | 56.2% | -20.4% | 22.4% | 144.0% | -0.4% | -15.5% | -32.1% | 70.5% | |
| Total Assets | -27.5% | 215.7% | 217.0% | -38.4% | 95.7% | -2.6% | 9.2% | -22.5% | -73.4% | 1011.6% | |
| Book Value / Share | -32.8% | 297.1% | 293.5% | -48.2% | 103.9% | -20.0% | -8.2% | -36.0% | -82.4% | -38.4% | |
| Debt | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Diluted Shares | 2.3% | 16.6% | 5.3% | 14.0% | 1.0% | 19.5% | 17.4% | 21.1% | 17.4% | 2052.4% |
Valuation
P/E (TTM)At Loss
P/S0.00
P/B2.03
10Y Low / Med / High1.12 / 9.53 / 31.17
EV/EBITDAAt Loss
10Y Low / Med / High5949.27 / 10239.16 / 35491.10
EV/Revenue0.00
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$0.08
Tangible Book / Share
$1.85
Net Current Assets / Share
$1.43
Graham Net-Net
$1.18
Cash / Share
$0.94
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -3.13 | -5.26 | -25.60 | -18.55 | -10.97 | -2.38 | -1.27 | -0.88 | -1.28 | -3.12 | -3.60 | |
| P/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| P/B Ratio | 31.17 | 9.53 | 13.25 | 18.72 | 7.13 | 3.35 | 1.56 | 1.12 | 5.52 | 19.69 | 2.03 | |
| EV/EBITDA | 35491.10 | 5949.27 | 10239.16 | -17.61 | 0.00 | -1.67 | -0.43 | -0.06 | -0.99 | -30.96 | -3.70 | |
| EV/Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analyst Estimates & Quality
Altman Z-Score
12.50
Safe
Piotroski F-Score
2
Weak